CN Patent

CN104161752B — 一种维格列汀组合物

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2018-09-07 · 8y expired

What this patent protects

本发明涉及一种维格列汀组合物。具体而言，所述组合物包括维格列汀以及（a）一种或一种以上药用稀释剂；（b）一种或一种以上崩解剂；（c）润滑剂；任选地，所述制剂中还包括其他药用辅料，所述组合物不使用脂肪酸的镁盐作为润滑剂。本发明的组合物具有更好的稳定性和药物溶出度。

USPTO Abstract

本发明涉及一种维格列汀组合物。具体而言，所述组合物包括维格列汀以及（a）一种或一种以上药用稀释剂；（b）一种或一种以上崩解剂；（c）润滑剂；任选地，所述制剂中还包括其他药用辅料，所述组合物不使用脂肪酸的镁盐作为润滑剂。本发明的组合物具有更好的稳定性和药物溶出度。

Drugs covered by this patent

metformin-hydrochloride (METFORMIN HYDROCHLORIDE)

Patent Metadata

Patent number: CN104161752B
Jurisdiction: CN
Classification: —
Expires: 2018-09-07
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.